Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3491 Neoplasms 2738 Prostatic Neoplasms 1580 Colorectal Neoplasms 1243 Lung Neoplasms 1184 Motor Activity 763 Head and Neck Neoplasms 619 Pancreatic Neoplasms 600 Colonic Neoplasms 586 Uterine Cervical Neoplasms 563 Carcinoma, Non-Small-Cell Lung 559 Carcinoma, Hepatocellular 556 Rectal Neoplasms 514 Stomach Neoplasms 490 Brain Neoplasms 435 Anxiety Disorders 400 Ovarian Neoplasms 396 Pain 375 Esophageal Neoplasms 347 Neoplasm Metastasis 340 Polycystic Ovary Syndrome 339 Fatigue 323 Urinary Bladder Neoplasms 314 Precursor Cell Lymphoblastic Leukemia-Lymphoma 303 Melanoma 298 Depression 285 Multiple Myeloma 281 Endometrial Neoplasms 262 Lymphoma 257 Hematologic Neoplasms 250

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × CRC × Clear all

NCT03337776 2021-08-05

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

Chinese University of Hong Kong

Phase NA Withdrawn

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡